Gilead Sciences

Gilead Sciences as of June 30, 2025

Portfolio Holdings for Gilead Sciences

Gilead Sciences holds 14 positions in its portfolio as reported in the June 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Galapagos Nv Spon Adr (GLPG) 36.5 $468M 17M 27.99
Arcellx Common Stock (ACLX) 34.6 $443M 6.7M 65.85
Arcus Biosciences Incorporated (RCUS) 20.0 $256M 31M 8.14
Assembly Biosciences Com New (ASMB) 3.1 $40M 2.2M 18.12
Tango Therapeutics (TNGX) 1.9 $25M 4.9M 5.12
Merus N V (MRUS) 1.9 $24M 453k 52.60
Kyverna Therapeutics (KYTX) 1.0 $13M 4.1M 3.07
Xilio Therapeutics (XLO) 0.5 $6.2M 9.1M 0.68
Hookipa Pharma Com New (HOOK) 0.2 $2.4M 1.9M 1.25
Leap Therapeutics Com New (LPTX) 0.1 $1.6M 5.3M 0.30
Allogene Therapeutics (ALLO) 0.1 $1.3M 1.2M 1.13
Kalaris Therapeutics (KLRS) 0.1 $849k 318k 2.67
Ikena Oncology (IKNA) 0.0 $467k 349k 1.34
Barinthus Biotherapeutics Pl Ads (BRNS) 0.0 $93k 100k 0.93